Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Therapeutic Areas
1.2.2. Distribution Channel
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Therapeutic Areas outlook
2.2.2. Distribution Channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. North America Topical Skin Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of skin diseases
3.2.1.2. Increasing adoption of topical treatments
3.2.1.3. Growing demand for faster and more effective results
3.2.2. Market restraint analysis
3.2.2.1. Skin irritation and allergies caused by topical drugs
3.2.2.2. Preference for alternative modes of drug delivery
3.2.3. Market opportunity analysis
3.2.3.1. Emerging biologic topical treatments for psoriasis
3.2.3.2. Innovative topical therapies for nonmelanoma skin cancer
3.2.3.3. Growth potential in advanced acne treatment solutions
3.3. North America Topical Skin Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
Chapter 4. North America Topical Skin Treatment Market: Therapeutic Areas Estimates & Trend Analysis
4.1. North America Topical Skin Treatment Market: Therapeutic Areas Dashboard
4.2. North America Topical Skin Treatment Market: Therapeutic Areas Movement Analysis
4.3. North America Topical Skin Treatment Market: By Therapeutic Areas, Revenue (USD million)
4.4. Skin Cancer
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Fluorouracil (5-FU)
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Imiquimod
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Ingenol Mebutate
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Diclofenac Sodium Gel
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Tirbanibulin Ointment
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Eczema
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Corticosteroids
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Calcineurin Inhibitors
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Crisaborole (Eucrisa)
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. Topical Antimicrobials
4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Emollients and Moisturizers
4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.7. Others
4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Psoriasis
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Corticosteroids
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Vitamin D Analogues
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Coal Tar
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Tazarotene
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.6. Topical Calcineurin Inhibitors
4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.7. Combination Therapies
4.6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.8. Others
4.6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Other therapeutic areas
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. North America topical skin treatment market: Distribution Channel Estimates & Trend Analysis
5.1. North America topical skin treatment market: Distribution Channel Dashboard
5.2. North America topical skin treatment market: Distribution Channel Movement Analysis
5.3. North America topical skin treatment market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
5.4. Hospital Pharmacies
5.4.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Retail Pharmacies
5.5.1. Retail pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Online pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. North America topical skin treatment market: Regional Estimates & Trend Analysis By Therapeutic Areas, and Distribution Channel
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2023
7.3.2. Johnson & Johnson Services, Inc.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. GSK Plc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Pfizer, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Novartis AG
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. LEO Pharma A/S
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. AbbVie, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Bausch Health Companies, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Galderma
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Sun Pharmaceutical Industries Ltd.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives



List of Figures

List of Figures

Fig. 1 North America Topical Skin Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic areas and distribution channel snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Pharmaceutical market value, 2023 (USD billion)
Fig. 12 Market trends & outlook
Fig. 13 Melanoma cases in 2021
Fig. 14 Porter’s five force analysis
Fig. 15 PESTEL analysis
Fig. 16 North America topical skin treatment market: Therapeutic areas outlook and key takeaways
Fig. 17 North America topical skin treatment market: Therapeutic areas movement analysis
Fig. 18 Skin cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Skin cancer cases in 2022
Fig. 20 Fluorouracil (5-FU) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Imiquimod market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Ingenol mebutate market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Diclofenac sodium gel market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Tirbanibulin ointment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Eczema market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Prevalence of Atopic Dermatitis (AD) in 2023
Fig. 28 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Crisaborole (Eucrisa) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Topical antimicrobials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Emollients and moisturizers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Psoriasis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Psoriasis cases (Million)
Fig. 36 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Vitamin D analogs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Coal tar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Tazarotene market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Topical calcineurin inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Combination therapies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 North America topical skin treatment market: Distribution channel outlook and key takeaways
Fig. 45 North America topical skin treatment market: Distribution channel movement analysis
Fig. 46 Skin cancer, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Skin cancer, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Skin cancer, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Eczema, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Eczema, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Eczema, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Psoriasis, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Psoriasis, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Psoriasis, other, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Other, hospital pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Other, retail pharmacy, market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 North America topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 U.S. North America Topical Skin Treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Canada topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Mexico topical skin treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Market participant categorization
Fig. 66 Company market share analysis, 2023
Fig. 67 Strategic framework

List of Tables

List of Tables

Table 1 List of abbreviation
Table 2 North America topical skin treatment market, by region, 2018 - 2030 (USD Million)
Table 3 North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 4 North America topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 U.S. North America topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 6 U.S. topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Canada topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 8 Canada topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 Mexico topical skin treatment market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 10 Mexico topical skin treatment market, by distribution channel, 2018 - 2030 (USD Million)